Meena D., Huang J., Zare M., Hasbani NR., Romuald BP., Mustafa R., van der Laan SW., Xu H., Terry JG., Bis JC., Jain D., Palmer ND., Heard-Costa N., Min Y-I., Guo X., Yao J., Taylor KD., Tan J., Peralta J., Pereira AC., Khan A., Choudhury A., Newman AB., Xiang AH., Hingorani A., Freedman BI., O'Donnell CJ., Giambartolomei C., Herrington DM., Jacobs DR., Klarin D., Wang FF., Heiss G., Doddapaneni H., Hodis HN., Broome J., Wilson JG., Brandenburg J-T., Blangero J., Krieger JE., Smith JD., Viaud-Martinez KA., Ryan KA., Lange LA., Montasser ME., Mahaney MC., Mokry M., Fornage M., Munroe P., Gibbs RA., Tracy RP., Kim RW., Damrauer SM., Rich SS., Hsueh WA., Chen Y-DI., NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium, The Million Veteran Program (MVP), TOPMed Atherosclerosis Working Group ., Morrison AC., Mitchell BD., Carr JJ., Psaty BM., Bowden DW., Vasan RS., Correa A., Post WS., Goodarzi MO., Raffel LJ., Curran JE., Ramsay M., Rotter JI., Elliott P., Franceschini N., de Vries PS., Tzoulaki I., Dehghan A.